Synaptys Neuroscience: preventing Alzheimer’s disease with combination therapy
… innovation cluster. Innovation Sébastien Lasnier, a former pharmaceutical industry professional who switched to … other hydrophilic. One of them acts as an anti-glutamate agent, glutamate being the main excitatory neurotransmitter … candidate, the start-up went through four stages. The first was to identify the right molecules, which took two years. …
Published on: